Hunt Jennifer M, Gjoka Glenda
Institute for Health Services Research, University of Luton.
Nurs Times. 2003;99(49):24-5.
Even though all drugs are extensively tested before marketing, the need for continuous postmarketing surveillance is now greater than ever. In 2002, 16,176 adverse drug reaction reports were received, of which 67 per cent related to reactions categorised as 'serious'. Nurse reporting of adverse drug reactions has almost doubled in the past year since nurses were officially allowed to participate in the yellow-card scheme for identifying adverse drug reactions (NT Clinical news, 2 December, p7). Nurses, through their close contact with patients, are ideally placed to be a key source of information on adverse drug reactions in the UK's yellow-card scheme.
尽管所有药物在上市前都经过了广泛测试，但如今对上市后持续监测的需求比以往任何时候都更为迫切。2002年，共收到16176份药品不良反应报告，其中67%与被归类为“严重”的反应有关。自护士被正式允许参与识别药品不良反应的黄卡计划以来，过去一年护士报告的药品不良反应几乎翻了一番（《NT临床新闻》，12月2日，第7页）。在英国的黄卡计划中，护士通过与患者的密切接触，处于提供药品不良反应信息的理想关键位置。
